...a cholic acid-based agonist of GPBAR1, in preclinical testing to treat Type II diabetes. Sensor Pharmaceuticals Inc....

...to the regulation of GPR120 was not known," said Jim Hauske, president and founder of Sensor Pharmaceuticals Inc....
...London, U.K. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Metabolon Inc. , Durham, N.C. Sensor Pharmaceuticals Inc....

...New York, N.Y. Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass. Sensor Pharmaceuticals Inc. , San Diego, Calif. Sidebars Sensor Pharmaceuticals Inc....